The evolution and international spread of extensively drug resistant Shigella sonnei.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
08 04 2023
Historique:
received: 12 09 2022
accepted: 24 03 2023
medline: 11 4 2023
entrez: 8 4 2023
pubmed: 9 4 2023
Statut: epublish

Résumé

Shigella sonnei causes shigellosis, a severe gastrointestinal illness that is sexually transmissible among men who have sex with men (MSM). Multidrug resistance in S. sonnei is common including against World Health Organisation recommended treatment options, azithromycin, and ciprofloxacin. Recently, an MSM-associated outbreak of extended-spectrum β-lactamase producing, extensively drug resistant S. sonnei was reported in the United Kingdom. Here, we aimed to identify the genetic basis, evolutionary history, and international dissemination of the outbreak strain. Our genomic epidemiological analyses of 3,304 isolates from the United Kingdom, Australia, Belgium, France, and the United States of America revealed an internationally connected outbreak with a most recent common ancestor in 2018 carrying a low-fitness cost resistance plasmid, previously observed in travel associated sublineages of S. flexneri. Our results highlight the persistent threat of horizontally transmitted antimicrobial resistance and the value of continuing to work towards early and open international sharing of genomic surveillance data.

Identifiants

pubmed: 37031199
doi: 10.1038/s41467-023-37672-w
pii: 10.1038/s41467-023-37672-w
pmc: PMC10082799
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1983

Subventions

Organisme : Medical Research Council
ID : MR/R020787/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/V009184/1
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2023. The Author(s).

Références

Microb Genom. 2019 Nov;5(11):
pubmed: 31682221
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17522-7
pubmed: 24082120
PLoS Med. 2016 Aug 02;13(8):e1002055
pubmed: 27483136
Open Forum Infect Dis. 2020 Apr 18;7(4):ofaa113
pubmed: 32341933
Antimicrob Agents Chemother. 2020 Nov 17;64(12):
pubmed: 33020158
PLoS Biol. 2021 Nov 9;19(11):e3001421
pubmed: 34752446
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Nucleic Acids Res. 2015 Feb 18;43(3):e15
pubmed: 25414349
Genome Res. 2018 Sep;28(9):1395-1404
pubmed: 30049790
Emerg Infect Dis. 2016 Sep;22(9):1545-53
pubmed: 27532625
Nat Commun. 2021 May 11;12(1):2684
pubmed: 33976138
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Lancet Infect Dis. 2022 Oct;22(10):1503-1510
pubmed: 35809593
Int J STD AIDS. 2021 Oct;32(11):1081-1083
pubmed: 34125636
Euro Surveill. 2015 Apr 16;20(15):
pubmed: 25953129
PLoS One. 2012;7(10):e47239
pubmed: 23071767
Nat Microbiol. 2020 Feb;5(2):256-264
pubmed: 31959970
Am J Epidemiol. 1975 Apr;101(4):323-32
pubmed: 1092157
J Clin Microbiol. 2020 Mar 25;58(4):
pubmed: 31969425
BMC Bioinformatics. 2016 Apr 19;17:172
pubmed: 27094401
Mol Biol Evol. 2013 May;30(5):1224-8
pubmed: 23408797
Vaccine. 2019 Aug 7;37(34):4784-4786
pubmed: 30711317
Wellcome Open Res. 2019 Dec 2;4:191
pubmed: 32055708
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Curr Opin Infect Dis. 2018 Oct;31(5):449-454
pubmed: 30048255
J Hyg (Lond). 1968 Sep;66(3):479-87
pubmed: 4877760
Bioinformatics. 2012 Oct 15;28(20):2678-9
pubmed: 22914218
Nat Commun. 2018 Apr 13;9(1):1462
pubmed: 29654279
J Infect Dis. 1971 May;123(5):477-84
pubmed: 4329896
Proc Biol Sci. 2022 Aug 10;289(1980):20220581
pubmed: 35919999
Microb Genom. 2021 Aug;7(8):
pubmed: 34427554
Int J STD AIDS. 2020 Jan;31(1):4-15
pubmed: 31870237
MMWR Morb Mortal Wkly Rep. 2020 Dec 18;69(50):1911-1916
pubmed: 33332296
J Med Microbiol. 2016 Aug;65(8):882-884
pubmed: 27302408
Lancet. 2018 Feb 24;391(10122):801-812
pubmed: 29254859
J Infect. 2005 Oct;51(3):222-9
pubmed: 16230220
PLoS Comput Biol. 2017 Jun 8;13(6):e1005595
pubmed: 28594827
Microb Genom. 2020 Mar;6(3):
pubmed: 32100710
Gigascience. 2021 Feb 16;10(2):
pubmed: 33590861
Crit Rev Food Sci Nutr. 2006;46(7):551-67
pubmed: 16954064
Genome Res. 2020 Jan;30(1):138-152
pubmed: 31809257
Nucleic Acids Res. 2021 Jul 2;49(W1):W293-W296
pubmed: 33885785
Sci Rep. 2021 Apr 29;11(1):9256
pubmed: 33927221
Bioinformatics. 2016 Oct 1;32(19):3047-8
pubmed: 27312411
Bioinformatics. 2011 Nov 1;27(21):2987-93
pubmed: 21903627
BMC Genomics. 2011 Aug 08;12:402
pubmed: 21824423
Clin Microbiol Infect. 2021 Jan;27(1):126.e7-126.e13
pubmed: 32247893
Lancet Infect Dis. 2015 Aug;15(8):913-21
pubmed: 25936611
Genome Biol. 2015 Dec 29;16:294
pubmed: 26714481
Sci Rep. 2021 Jun 16;11(1):12728
pubmed: 34135355
Acta Clin Belg. 2022 Feb;77(1):186-194
pubmed: 32484428
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
BMJ Open. 2022 Mar 21;12(3):e050469
pubmed: 35314468
Bioinformatics. 2013 Apr 15;29(8):1072-5
pubmed: 23422339
Bull World Health Organ. 2022 Apr 1;100(4):239-239A
pubmed: 35386562
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
mBio. 2021 Apr 27;12(2):
pubmed: 33906921
Sci Rep. 2018 May 9;8(1):7389
pubmed: 29743642
J Med Microbiol. 2021 Oct;70(10):
pubmed: 34665107
PLoS One. 2014 Nov 19;9(11):e112963
pubmed: 25409509
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Bioinformatics. 2021 Aug 25;37(16):2473-2475
pubmed: 33459763
Wellcome Open Res. 2018 Jul 30;3:93
pubmed: 30345380
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Nat Genet. 2012 Sep;44(9):1056-9
pubmed: 22863732
Nat Commun. 2015 Dec 21;6:10063
pubmed: 26686880

Auteurs

Lewis C E Mason (LCE)

NIHR HPRU in Gastrointestinal Infections at University of Liverpool, Liverpool, UK.
Department of Clinical Infection, Microbiology, and Immunology; Institute for Infection, Veterinary and Ecological Sciences, Liverpool, UK.

David R Greig (DR)

Gastro and Food Safety (One Health) Division, UK Health Security Agency, London, UK.

Lauren A Cowley (LA)

Milner Centre for Evolution, University of Bath, Bath, UK.

Sally R Partridge (SR)

Centre for Infectious Diseases and Microbiology, The Westmead Institute for Medical Research, Westmead, NSW, Australia.
Western Sydney Local Health District, Westmead, NSW, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Sydney Infectious Diseases Institute, University of Sydney, Sydney, NSW, Australia.

Elena Martinez (E)

Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
New South Wales Health Pathology, Dee Why, NSW, Australia.

Grace A Blackwell (GA)

Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
New South Wales Health Pathology, Dee Why, NSW, Australia.

Charlotte E Chong (CE)

Department of Clinical Infection, Microbiology, and Immunology; Institute for Infection, Veterinary and Ecological Sciences, Liverpool, UK.

P Malaka De Silva (PM)

Department of Clinical Infection, Microbiology, and Immunology; Institute for Infection, Veterinary and Ecological Sciences, Liverpool, UK.

Rebecca J Bengtsson (RJ)

Department of Clinical Infection, Microbiology, and Immunology; Institute for Infection, Veterinary and Ecological Sciences, Liverpool, UK.

Jenny L Draper (JL)

Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
New South Wales Health Pathology, Dee Why, NSW, Australia.

Andrew N Ginn (AN)

Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Sydney Infectious Diseases Institute, University of Sydney, Sydney, NSW, Australia.
New South Wales Health Pathology, Dee Why, NSW, Australia.
Douglass Hanly Moir Pathology, Macquarie Park, NSW, Australia.

Indy Sandaradura (I)

Western Sydney Local Health District, Westmead, NSW, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
New South Wales Health Pathology, Dee Why, NSW, Australia.

Eby M Sim (EM)

Centre for Infectious Diseases and Microbiology, The Westmead Institute for Medical Research, Westmead, NSW, Australia.
Western Sydney Local Health District, Westmead, NSW, Australia.
Sydney Infectious Diseases Institute, University of Sydney, Sydney, NSW, Australia.

Jonathan R Iredell (JR)

Centre for Infectious Diseases and Microbiology, The Westmead Institute for Medical Research, Westmead, NSW, Australia.
Western Sydney Local Health District, Westmead, NSW, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Sydney Infectious Diseases Institute, University of Sydney, Sydney, NSW, Australia.

Vitali Sintchenko (V)

Centre for Infectious Diseases and Microbiology, The Westmead Institute for Medical Research, Westmead, NSW, Australia.
Western Sydney Local Health District, Westmead, NSW, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Sydney Infectious Diseases Institute, University of Sydney, Sydney, NSW, Australia.
New South Wales Health Pathology, Dee Why, NSW, Australia.
Centre for Infectious Diseases and Microbiology - Public Health, Institute for Clinical Pathology and Microbiology Research, Westmead Hospital, Westmead, NSW, Australia.

Danielle J Ingle (DJ)

Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.

Benjamin P Howden (BP)

Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.

Sophie Lefèvre (S)

Institut Pasteur, Université Paris Cité, Unité des Bactéries pathogènes entériques, Centre National de Référence des Escherichia coli, Shigella et Salmonella, Paris, F-75015, France.

Elisabeth Njamkepo (E)

Institut Pasteur, Université Paris Cité, Unité des Bactéries pathogènes entériques, Centre National de Référence des Escherichia coli, Shigella et Salmonella, Paris, F-75015, France.

François-Xavier Weill (FX)

Institut Pasteur, Université Paris Cité, Unité des Bactéries pathogènes entériques, Centre National de Référence des Escherichia coli, Shigella et Salmonella, Paris, F-75015, France.

Pieter-Jan Ceyssens (PJ)

Division of Human Bacterial Diseases, Sciensano, Ixelles, Belgium.

Claire Jenkins (C)

Gastro and Food Safety (One Health) Division, UK Health Security Agency, London, UK.

Kate S Baker (KS)

NIHR HPRU in Gastrointestinal Infections at University of Liverpool, Liverpool, UK. kbaker@liverpool.ac.uk.
Department of Clinical Infection, Microbiology, and Immunology; Institute for Infection, Veterinary and Ecological Sciences, Liverpool, UK. kbaker@liverpool.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH